This is important because ERß appears to be associated with antiproliferative, anticarcinogenic effects, while ERα is thought to promote carcinogenesis, and is the form measured clinically in the treatment of breast cancer patients [176,177]. This evidence concerns the gene ESR1 and breast cancer.